Shares in food ingredients group DSM closed down more than 3% today (2 November) after the company’s operating profit in the third quarter missed analyst estimates.
DSM, which makes enzymes, cultures and yeast extracts for dairy, baking and savoury manufacturers, booked a 28% increase in operating profit from continuing operations to EUR185m. Net sales rose 19% to EUR2.15bn.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
However, analysts polled by Bloomberg and Reuters had expected group operating profit of EUR204m.
Chairman Feike Sijbesma said DSM had had “another strong quarter” and insisted that the “continued positive business environment” meant the company expected 2010 to be “a strong year”.
Sijbesma said DSM’s nutrition business had “delivered a continued excellent performance”. Operating profit from the unit rose 15% to EUR137m. Sales rose 7% to EUR751m, driven by foreign exchange. On an organic basis, sales were flat.
DSM shares finished the day’s trading down 3.4% at EUR37.19.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataClick here for the full statement from DSM.
